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7. Summary 
 
Histological evaluation of a bioactive implant for spondylodesis in the cervical spine (an 
experimental study in a sheep model) 
 
The fusion of vertebral segments is an established treatment for spinal disorders. Harms-
Cages were used as intervertebral implants for spondylodesis since 1986. This cage is 
originally filled with autologous cancellous bone graft which promotes bone remodeling with 
its osteoinductive and osteoconductive properties. 
 
The purpose of this in vivo study was the histomorphological and histomorphometrical 
comparison of a sheep cervical spine fusion-model by using the Harms-Cage. Thirty-one 
sheep underwent C3 / C4 discectomy and fusion. They were divided into four groups, 
according to their treatment: group 1: Harms-Cage filled with mineralized collagen scaffold (n 
= 8); group 2: Harms-Cage filled with mineralized collagen scaffold combined with PRP (n = 
8); group 3: Harms-Cage filled with mineralized collagen scaffold combined  with 150 µg rh 
BMP-2 (n = 8); group 4: Harms-Cage filled with mineralized collagen scaffold coated with 
cyclic RGD-Peptide (n = 7); group 5: untreated control segment (n = 8). Group 5 acted as 
referee. After 12 weeks, sheep were sacrificed and specimen were taken. Histological 
handling followed. All specimen were stained with masson – goldner - trichrom, safranin - 
orange / lightgreen, safranin – orange / von Kossa and astrablue. The quantitative analysis 
showed the intervertebral tissue, vascularisation and foreign body reaction in the former 
intervertebral disc-space. The following histomorphometrical analysis calculated the 
percentage rate of bone, cartilage and mineralized cartilage in the defined “Region of 
Interest” (ROI). 
 
The histological analysis revealed the following results: The vertebral disc-space was filled 
with fibrous tissue and cartilage in group 1. Partially residual tissue of mineralized collagen 
was demonstrated. In one specimen a bony fusion could be detected. The specimens of 
group 2 showed no bony fusion at all. Vertebral bodies were separated by a layer of fibrous 
tissue and cartilage in contact to new built bone. Group 3 was characterized by advanced 
bone modeling and remodeling even ventral of the vertebral disc space. Three specimens 
showed bony fusion. The specimens of group 4 showed advanced bone regeneration. Two 




All specimens of the groups 1, 3 and 4 presented significantly more bone tissue in the 
examined area than the native specimens. There was no significant difference in mineralized 
cartilage between all examined groups. The results showed that all tested treatments for 
spinal fusion have the ability for equally replacing the bone graft - “Golden Standard” at the 
12-week examination time point. The cage augmentation with mineralized collagen scaffold 
(group 1) and mineralized collagen scaffold combined with PRP (group 2) did not show a 
significant effect on the interbody fusion and bone growth. Foreign body reactions were 
associated with cage sintering. 
 
The additional treatment of the interbody fusion device with rh BMP-2 (group 3) and the 
cyclic RGD-Peptide (group 4) was a successful combination for the application in the cervical 
spine. Both methods showed better results than the Harms-Cage filled with autologous bone 
graft. Nevertheless the usage of rh BMP-2 for spinal fusion is associated  with some risks, 
specified in literature. In this study, no complications were found. It can be suggested that the 
ventral bony callus is caused by the method of application of the growth factor at the 
mineralized collagen scaffold and not by rh BMP-2 itself. Nevertheless the use of rh BMP-2 
on collagen scaffolds should be limited to experimental studies. The combination of 
mineralized collagen scaffold with the cyclic RGD-peptide, which usage is confined to 
experimental studies so far, stimulated the spondylodesis as well in this animal model. This 
occurred without any side effects, like foreign body reactions, within the observation period. 
The combination of cyclic RGD-peptide with an osteoconductive matrix showed very good 
results for spondylodesis and was superior to the autologous transplant. This showed 
impressively, that cRGD is able to accelerate osseointegration and bone modeling, without 
side effects within a 12-weeks observation period. This peptide should be examined in long 
term studies to exclude any side effects. 
 
